Skip to content
Verified quality
Contact support
Physician recommendation required · Educational information, not medical advice
Dripfy
TB-500 (Thymosin Beta-4)
≥99% HPLCPre-filled pen

TB-500 (Thymosin Beta-4)

What it is?

TB-500 is a synthetic form associated with Thymosin Beta-4 activity, studied for its role in tissue repair signalling and inflammation balance. It is commonly positioned for protocols targeting recovery, mobility restoration, and connective tissue resilience.

Dripfy Advantage

  • Regeneration signalling: Supports repair pathways linked to tissue remodelling and recovery following mechanical stress.
  • Angiogenesis support: Associated with vascular signalling that can support oxygen and nutrient delivery to recovering tissue.
  • Cell migration dynamics: Studied for its role in cell migration and tissue re-organisation during repair processes.
  • Inflammation modulation: May influence inflammatory signalling balance, supporting recovery environments without prolonged inflammatory load.
  • Oxidative stress interface: Frequently positioned in protocols where oxidative stress markers are relevant during tissue recovery cycles.

Clinical Applications & Therapeutic Potential

  • Connective tissue recovery: Positioned for tendon and ligament recovery endpoints and joint resilience signalling in musculoskeletal models.
  • Post-injury mobility outcomes: Potential support for flexibility and range-of-motion recovery through tissue remodelling dynamics.
  • Inflammation and discomfort pathways: Potential reduction in inflammation-associated markers and improved recovery comfort endpoints.
  • Training recovery protocols: Often included in performance settings to support faster recovery kinetics after intense load.

Composition & Formulation

  • Peptide content: 5 mg TB-500
  • Vehicle: Proprietary pH-balanced buffer solution
  • Delivery system: Pre-filled, multi-dose, closed-system pen
  • Total volume: 3 mL
  • Purity: ≥99% by HPLC/MS
€413

Submit an enquiry and we arrange the consultation, physician review and shipping. Physician recommendation required; not medical advice.

Purity
≥99%
Form
Pre-filled pen
Download Certificate of Analysis
Certificate of Analysis available on request

Important medical notice

  • A physician recommendation is mandatory before use.
  • The information on this website is educational only and is not medical advice, diagnosis, or treatment.
  • Always consult a qualified physician before starting any peptide.
  • Dosing is individualised and determined by your treating physician.

Peptide Practice Guide

Each card summarises what the peptide is studied for and its evidence strength. It is not a recommendation. Dosing and suitability are decided by your physician.

TB-500 (Thymosin Beta-4)

Investigational synthetic Thymosin Beta-4-related peptide (regenerative) · Pre-filled pen

D· Preliminary evidence

TB-500 is a synthetic peptide associated with Thymosin Beta-4 activity. In animal and cell studies it is linked to regulation of actin, cell migration, angiogenesis and modulation of inflammation, which together support tissue re-organisation during repair. Robust controlled human trials are lacking, so its recovery claims remain research-level.

Studied use areas

  • Musculoskeletal and soft-tissue recovery (research context)
  • Connective-tissue resilience
  • Cell migration and tissue remodelling
  • Angiogenesis and tissue perfusion
  • Inflammation balance during recovery

Safety & status

  • Investigational and not an approved medicine; controlled human safety data are lacking
  • Prohibited in competitive sport under the WADA prohibited list
  • Product purity and source quality can vary and affect risk
  • Use only under qualified physician oversight

Clinical note: This card is educational and is not medical advice. TB-500 is investigational; any use must be individualised and determined by the treating physician.

Evidence: Investigational — mainly animal and cell data; no approved human indication · References: peer-reviewed regenerative-medicine and preclinical tissue-repair literature; EMA/MHRA regulatory-status information on unapproved peptides; sports anti-doping (WADA) prohibited-substance listings

Related peptides